In a report released today, Ivan Feinseth from Tigress Financial reiterated a Buy rating on Hims & Hers Health (HIMS – Research Report), with a price target of $15.00.
Ivan Feinseth has given his Buy rating due to a combination of factors that highlight the robust growth trajectory of Hims & Hers Health. The analyst points to the company’s highly scalable business model and the expansion of services as key drivers of significant revenue growth. Feinseth also notes the introduction of a holistic weight loss program, which is expected to serve as a major catalyst for the company’s growth. Furthermore, the growing customer base, larger order sizes, and increasing volume, coupled with new product launches and expansion into fresh treatment areas, are anticipated to sustain the acceleration in business performance and support the company’s path to economic profitability.
Additionally, Hims & Hers Health is seen as being strategically positioned to capitalize on the evolving healthcare market, with a focus on catering to value-conscious consumers and introducing new products to stimulate further growth. Feinseth underscores the company’s ability to disrupt the large and fragmented healthcare industry by offering low-cost and efficient access to care. The report also emphasizes the company’s strategic use of cash flow, which will be directed towards funding new growth opportunities, enhancing digital capabilities, and marketing initiatives. Moreover, the initiation of a share repurchase program is expected to further signal the company’s commitment to delivering shareholder value, reinforcing the Buy rating provided by Feinseth.
See Insiders’ Hot Stocks on TipRanks >>
Based on the recent corporate insider activity of 123 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of HIMS in relation to earlier this year.
TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. By upgrading to TipRanks Premium, you will gain access to this exclusive data and discover crucial insights to guide your investment decisions. Begin your TipRanks Premium journey today.
Hims & Hers Health (HIMS) Company Description:
Oaktree Acquisition Corp. is an emerging growth company, which engages in the provision of merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by Patrick McCaney, Alexander Taubman and Mathew Pendo in 2019 and is headquartered in Los Angeles, CA.
Read More on HIMS:
